A clinical trial to study the effect of newer local anesthetic levobupivacaine in comparison with bupivacaine for spinal anesthesia.
Phase 3
Completed
- Registration Number
- CTRI/2009/091/000736
- Lead Sponsor
- aprod Lifesciences Pvt Ltd.Reg Office 304, Town Centre, Andheri-Kurla Road, Andheri, Mumbai- 400059
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
1. ASA Grade I and II. 2. Weight - 50 to 80 kg.
3. Height - 140 to 180 cm.
4. Age - 18 to 60 yrs.
5. Surgeries on the lower limbs, pelvis and lower abdomen.
Exclusion Criteria
1.Patient?s refusal to participate in the study.
2.ASA Grade III, IV and V.
3.Age below 18 years and above 60 years.
4.Weight below 30 kg and above 80 kg.
5.Patients with history of allergy to any drug.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To study local anaesthetic efficacy of intrathecal levobupicaine with respect to <br>a.Onset of action.<br>b.Duration of action.<br>c.Type of neural block.<br><br><br><br><br>Timepoint: To compare bupivacaine and levobupivacaine with respect to above parameters
- Secondary Outcome Measures
Name Time Method To evaluate whether levobupivacaine is a better long acting local anaesthetic as compared to bupivacaine.Timepoint: At the end of study and after statistical analysis.